Approval · Notice of Compliance 12779 · 2011
INTELENCE: Notice of Compliance 12779
Issued November 14, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12779
- Date
- November 14, 2011
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New Strength
- Therapeutic class
- Human Immunodeficiency Virus (HIV) Non-nucleoside Reverse Transcriptase Inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTELENCE | 02375931 | Marketed |
Medicinal ingredients
- ETRAVIRINE 200 MG per TAB